Carbidopa / Levodopa

In the US, Carbidopa/Levodopa (carbidopa/levodopa systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat GTP-CH Deficiency, Neuroleptic Malignant Syndrome, Parkinson's Disease and Restless Legs Syndrome.

US matches:

• Carbidopa/Levodopa


• Carbidopa/Levodopa Orally Disintegrating Tablets


• Carbidopa/Levodopa Sustained-Release Tablets


• Carbidopa/Levodopa/Entacapone

Ingredient matches for Carbidopa/Levodopa

Carbidopa

Carbidopa is reported as an ingredient of Carbidopa/Levodopa in the following countries:

• Romania

Levodopa

Levodopa is reported as an ingredient of Carbidopa/Levodopa in the following countries:

• Romania

International Drug Name Search